The etiology and mechanism causing Meniere’s disease (MD) are not understood. The present study investigated the possible molecular mechanism of autoimmunity and autoinflammation associated with MD. Thirty-eight patients with definite MD and 39 normal volunteers were recruited, and 48 human cytokines/chemokines were quantified. In patients with MD pure tone audiograms, tympanograms and standard blood tests were performed. The mean hearing loss in the worse ear was 44.1 dB nHL. Compared to the referents, the concentrations of TNFα, IL1α, IL8, CTACK, MIP1α, MIP1β, G-CSF, and HGF in the sera of patients with MD were significantly elevated, while those of TRAIL and PDGFBB were significantly decreased. The area under the receiver operating characteristic curve (AUC) showed that G-CSF, MIP1α, and IL8 were above 0.8 and could be used to diagnose MD (p < 0.01), and the AUCs of CTACK and HGF were above 0.7 and acceptable to discriminate the MD group from the control group (p < 0.01). The revised AUCs (1 − AUC) of TRAIL and PDGFBB were above 0.7 and could also be used in the diagnosis of MD (p < 0.01). The linear regression showed significant correlations between MIP1α and GCSF, between IL2Rα and GCSF, between IL8 and HGF, between MIP1α and IL8, and between SCF and CTACK; there was a marginal linear association between IP10 and MIP1α. Linear regression also showed that there were significant age-related correlations of CTACK and MIG expression in the MD group (p < 0.01, ANOVA) but not in the control group. We hypothesize that G-CSF, IL8, and HGF, which are involved in the development of neutrophil extracellular traps (NETs) and through various mechanisms influence the functions of macrophages, lymphocytes, and dendritic cells, among others, are key players in the development of EH and MD and could be useful in elucidating the pathophysiological mechanisms leading to MD. Biomarkers identified in the present study may suggest that both autoimmune and autoinflammatory mechanisms are involved in MD. In the future, it will be valuable to develop a cost-effective method to detect G-CSF, IL8, HGF, CTACK, MIP1α, TRAIL, and PDGFBB in the serum of patient that have diagnostic relevance.
Meniere’s disease (MD) is characterized by episodic vertigo accompanied by fluctuating sensorineural hearing loss, aural fullness, and tinnitus. The condition can be alleviated by dietary and lifestyle modifications, medication, and invasive interventions such as intratympanic steroid injection, intratympanic gentamicin injection, labyrinthectomy among others, but the etiology and mechanism causing MD are not understood1,2. Among the treatment modalities, intratympanic dexamethasone was reportedly capable of controlling vertigo in 91% of patients3, and in a randomized study, intratympanically administered corticosteroids were as effective as gentamicin to control vertigo4.
Brookes reported significantly increased circulating immune complex levels and an increased incidence of autoantibodies in MD, indicating an autoimmune mechanism5. Antibodies against bovine inner ear antigens were detected in the sera of MD patients6. An association of autoimmunity with familial patterns of MD leads to longer spells of MD7. A link between thyroid autoimmunity and MD was also proposed8,9. In addition to potential autoimmunity, autoinflammatory mechanisms may also be involved in the development of MD9,10,11,12,13,14,15. However, the detailed mechanism of eliciting either autoimmunity or autoinflammation involved in MD has not yet been clarified.
The endolymphatic sac (ES) is suggested to operate as an immune organ in situ, initiating the immune reaction in MD. A study on fresh human ES tissue using DNA microarrays and immunohistochemistry demonstrated multiple key elements of both the innate and adaptive immune reactions16. A preliminary study demonstrated that the proteins that appeared in the ES luminal fluid of patients with MD were associated with both innate and adaptive immune reactions17. Multiple genetic variants associated with innate immunity and immune regulation as well as the formation of inner ear structures and systemic hemostasis derangement were also detected in patients with sporadic MD in an East Asian population18. Therefore, both autoimmune and autoinflammatory reactions might be initiated in the endolymphatic sac of MD patients. If this occurs, then screening the cytokine/chemokine profile may provide a clue to understanding the detailed mechanism of the abovementioned immune reactions in MD patients.
The difference between human autoimmune responses and autoinflammatory responses is not distinctly defined and they may occur in the same subject simultaneously. Autoimmune diseases are characterized by the production of specific autoantibodies resulting from the loss of immune tolerance, the recognition of self-antigens and the activation of T cells and B cells, and these lead to damage to multiple organs owing to a dysregulated adaptive immune response. Cytokines, such as TNFα, IL-1β, and IL-6, are involved in processes modulated by their delivery in extracellular vesicles9,19,20. In contrast, autoinflammatory diseases are triggered without detectable autoantibodies or specific T cells and are mediated by cytosolic multiprotein complexes, so-called inflammasomes. Activation of the inflammasome leads to the cleavage of pro-interleukin (IL)-1β and the secretion of active IL-1β21. In addition, NF-κB and TNFα signaling are also activated in certain autoinflammatory diseases19. Mutations in MEFV, the gene encoding pyrin, which acts as an intra-nuclear regulator of transcription of the peptides involved in inflammation, mainly in the innate immune system and is an upstream signal of IL-1, have been defined as variants specific for autoinflammatory diseases and have been detected in MD15,19,22. However, many immunological diseases are mixed-pattern conditions that comprise elements of both autoimmunity and autoinflammation19,23.
The present study aimed to identify the cytokine profiles of MD and potential association to autoimmune/autoinflammatory mechanism in MD. The cytokine/chemokine profile in the sera of patients with definite MD was analyzed using premium Luminex.
Patients and methods
This study was carried out following the Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans that were further updated24, and the protocol was reviewed and approved by the ethics committee of Shanghai Changhai Hospital (CHEC2020-107). Written informed consent was obtained from all participants. The inclusion criteria were as follows: (1) a diagnosis of definite MD was made according to the criteria of the Barany Society in 201525 and (2) healthy volunteers without any history of chronic disease or complaining of acute disease. The exclusion criteria were patients with probable MD according to the abovementioned diagnostic criteria and patients with any diseases in the central nervous system, autoimmune or autoinflammatory disease and/or acute infection such as acute infection upper respiratory infection. However, MD patients accompanied by hypertension were not excluded. In total, 38 patients with definite MD (male:female = 1:1, aged 27–81, 53.6 ± 14.9 years) who visited author JZ at the Department of Otolaryngology-Head & Neck Surgery, Changhai Hospital, Second Military Medical University, from April to November 2021 and 39 normal volunteers (male:female = 1:1.17, aged 20–66, 36.2 ± 11.7 years) were recruited. Both the mean ages and range of healthy volunteers were younger than that of MD. All patients had audiological tests for pure tone audiograms and tympanograms and standard blood tests for immunoglobulins, transferrin, β2-microglobulin, α1-microglobulin, complement 3 (C3), C4, ceruloplasmin, anti-streptolysin O antibody, erythrocyte sedimentation rate, rheumatoid factor, C-reactive protein, and the total thyroid hormones triiodothyronine (T3) and thyroxine (T4).
Quantification of cytokines/chemokines
Two milliliters of blood was taken from each subject at 7:00 am before breakfast, and the serum was stored at − 80 °C until analysis. The time between the last attack and taking the blood sample varied from 1 to 7 weeks (mean 2.2 ± SD 1.8). The human cytokines/chemokines CTACK, FGF basic, G-CSF, GM-CSF, GRO-α, IFN-α2, IFN-γ, IL-1α, IL-1β, IL-1Rα, IL-2, IL-2Rα, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-12 (p40), IL-12 (p70), IL-13, IL-15, IL-16, IL-17, IL-18, IP-10, LIF, MCP-1, MCP-3, M-CSF, MIF, MIG, MIP-1α, MIP-1β, NGF-β, PDGF-BB, RANTES, SCF, SCGF-β, SDF-1α, TNF-α, TNF-β, and TRAIL were quantified using a Bio-Plex Pro Human Cytokine Screening Panel, 48-plex #12007283 (Bio-Plex Suspension Array System; Bio-Rad Laboratories Inc., Hercules, USA) according to the manufacturer's instructions. The antibody array experiment was performed by Wayen Biotechnology (Shanghai, China) according to their established protocol. In brief, a total of 50 μL of antibody-conjugated beads was added to the assay plate. Then, 50 μL of serum, standards, the blank, and the controls were added to the plate, and the plate was incubated in a dark room at ambient temperature with shaking at 850 rpm for 2 h. After washing 3 times, 50 μL of biotinylated antibody was added to the plate, which was incubated in a dark room at RT with shaking at 850 rpm for 1 h and then washed 3 times again. Subsequently, a total of 50 μL streptavidin–phycoerythrin was added to the plate. The plate was again incubated in a dark room at ambient temperature with shaking at 850 rpm for 30 min and then washed 3 times. Finally, the plate was read using a Bio-Plex MAGPIX Multiplex Reader (Bio-Rad, Hercules, USA). Bio-Plex Manager 6.0 software was used for data acquisition and analysis. We used a randomized double-blind protocol to evaluate these measurements.
SPSS 28.0 software was used for statistical analysis. For the phenotypes of MD, duration of the disease course, the time interval between the last vertigo attack and the cytokine assay, and both the average thresholds of the speech frequencies (0.5, 1.0, and 2.0 kHz) and that of the most severely impaired frequency (some patients only have hearing loss at one frequency during the early stage) were used in the analysis. For the general immunological phenotypes, C3 and C4 were used in the statistical analysis because only sparse cases demonstrated significant changes for the other tests. The measurements of GM-CSF, IFNα, IL-2, IL-3, IL-4, IL-6, IL-7, IL-10, IL-12(70), IL-12(40), IL-15, MCP-3, βNGF, and VEGF were not applied in the statistical analysis because their signal intensities were out of range of the standard curve. The measurements of eotaxin, GSCF, GROα, HGF, IL1Rα, IL2Rα, IL8, IL13, IL16, IL17, IP10, LIF, MCP1, MIG, MIP1α, MIP1β, PDGFBB, SCGFβ, TNFα, and TRAIL did not have normal distributions and were logarithmically converted to normalize the data. Independent t-tests were performed to compare cytokine/chemokine differences in subjects with MD to the referents, and in MD patients with hypertension to these without hypertension. For variables that showed significant differences in the above independent t-tests, ROC curve classification analysis was performed. Sensitivity, specificity, likelihood ratios, and the AUC of the ROC based on the trapezoidal rule were calculated and judged according to previously reported criteria26. Spearman’s rho test was applied to analyze correlations between age and cytokines/chemokines in both MD and referents, between the hearing level of the most severely impaired frequency, and the immunological phenotypes. Linear regression was performed between variables other than internal chemokine/cytokine correlations that showed significant correlations using Spearman’s rho test. The potential cytokine activation that may occur in uniform chain was formulated by exploring the Kendall’s tau between different cytokines among MD patients. p < 0.05 indicated statistical significance.
Ethics approval and consent to participate
The study was approved by the ethics committee of Shanghai Changhai Hospital.
Clinical characteristics of MD
Based on the clinical findings, 32 patients had unilateral MD and 6 had bilateral MD. The mean course of MD was 57.8 months (range 1 to 300 months). The mean threshold of hearing at speech frequencies was 44.1 dB nHL with a range of 17 to 88 dB nHL, while that of the most severely impaired frequency, with the majority at 250 Hz, varied from 25 to 115 dB nHL (mean 64.2 ± 25.5). From the standard laboratory tests of C3, C4, T3, transferrin, IgG, IgM, and ceruloplasmin, among others, we observed significant variations from normal laboratory values in a few individuals (Table 1).
Cytokines/chemokines and internal correlations
Compared to the healthy controls, the levels of TNFα, IL1α, IL8, CTACK, MIP1α, MIP1β, G-CSF, and HGF in the sera of patients with MD were significantly elevated, while those of TRAIL and PDGFBB were significantly decreased (independent sample t-test) (Supplementary information 1). In the detailed analysis, the AUC showed that G-CSF, MIP1α, and IL8 were above 0.8 and could be used to discriminate MD from the referents (p < 0.01), and the AUCs of CTACK and HGF were above 0.7 and assisted in discriminating the 2 groups (p < 0.01). The revised AUCs (1 − AUC) of TRAIL and PDGFBB were above 0.7 and were also useful for discrimination (p < 0.01) (Fig. 1; Table 2).
Within MD group, patients with hypertension had significantly higher levels of CTACK, IP10, MIG, IFNγ, and IL4 than these without hypertension (independent sample t-test) (Supplementary information 2). The AUC of CTACK, IP10, and MIG were above 0.7 (Fig. 2; Table 3).
Internal correlations were further analyzed using linear regression for variables that showed significant correlations by Spearman’s rho test (Supplementary information 3). The linear regression showed significant correlations between MIP1α and GCSF (R2 = 0.857, p < 0.001), between IL2Rα and GCSF (R2 = 0.358, p < 0.001), between IL8 and HGF (R2 = 0.413, p < 0.001), between MIP1α and IL8 (R2 = 0.812, p < 0.001), and between SCF and CTACK (R2 = 0.174, p < 0.01); there was a marginal linear association between IP10 and MIP1α (R2 = 0.116, p = 0.037) (Fig. 3). Linear regression also showed that there were significant negative correlations between the time of the last attack and PDGFBB (Fig. 4), and positive age-related correlations of CTACK (R2 = 0.394, p < 0.001) and MIG (R2 = 0.276, p < 0.001) expression in the MD group (p < 0.01, ANOVA) but not in the control group (Fig. 5).
We searched the association between different cytokines by exploring the Kendall’s tau (Supplementary information 4) between different cytokines to formulate which of the cytokine activation may occur in uniform chain. Thus, we grouped those with correlation coefficient greater than 0.7 in one group and those between 0.5 to 0.7 in another group as these could be indicate separate activation pattern. The cytokines IL8, MIP1α and GCSF had correlation greater than 0.7. In addition, the GSCF also activates TNFα. The cytokines IL1α, IL1β, IL16, bFGF, IL2Rα, IL4, LIF, and TNFα could form one additional activation branch. IL4, Eotaxin, IL17, and LIF form another branch.
Potent NET-associated activity indicated by elevated serum levels of chemokines in MD patients
We observed that various cytokines participating in autoimmunity and autoinflammation were up- and downregulated in MD. The AUC analysis showed that G-CSF, IL8, HGF, CTACK, MIP1α, TRAIL, and PDGFBB have diagnostic relevance, suggesting that these chemokines play an important role in MD. IL8, MIP1a and GCSF also had internal correlation greater than 0.7 indicting that they probably act in the same pathway and are activated by the same mechanisms. The G-CSF also correlated highly significantly with TNF-α indicating that the outcome of this pathway is harmful for inner ear. It was reported that G-CSF, IL8, and HGF are involved in the development of NETs through a mechanism by which G-CSF stimulates the production and release of neutrophils and primes neutrophil programming toward NET generation. HGF provokes neutrophils to release IL8, and IL8 together with HGF activate CXCR1 and CXCR2 to induce the formation of NETs27,28,29,30. A similar release of NETs from neutrophils has been identified as a mechanism used for bacterial killing31. NETs are network structures comprised of chromosomal DNA, granule proteins (myeloperoxidase, lactoferrin, neutrophil elastase, high mobility group box 1, cathepsin G, proteinase 3, and leucine-leucine-37), and citrullinated histone H3 that are catalyzed by PAD4 and released by neutrophils upon activation. Cytokine cascades of NETs are also involved in noninfectious diseases with the mechanisms of autoimmunity and autoinflammation32,33. Therefore, we hypothesize that NET formation might be involved in initiating the pathological process of MD as consequence of the enhanced production of specific chemokines (Fig. 6).
TRAIL is a member of the TNF superfamily, and is involved in the apoptotic removal of senescent, chronically activated, or stressed immune cells at sites of inflammation to regulate innate and adaptive immune responses by terminating the response and by limiting thereby tissue damage and the risk of autoimmunity34. Downregulation of TRAIL in MD patients may fail to sufficiently resolve the inflammation and causes the inflammatory impairment to enter a chronic course. PDGF‑BB has been reported to recruit mesenchymal cells, such as pericytes and smooth muscle cells, and induce their differentiation into fibroblasts to form fibrosis35. Downregulated PDGF-BB, and negative correlations between the time of the last attack and PDGFBB in MD patients in the current study might indicate that there is a mechanism in the body trying to prevent the formation of fibrosis.
Existence of molecular machinery in the inner ear and ES to form NETs
It has not yet been confirmed whether NET formation induced by these chemokines exists in the inner ear. It was recently reported that G-CSF is necessary for neutrophil recruitment in the cochlea of C57BL/6 mice following intravenous injection of lipopolysaccharide solution36. In DFNB39 mice, the associated nonsyndromic hearing loss resulted from noncoding mutations that may influence HGF-induced signaling37. There were significant correlations between the concentration of IL8 and that of G-CSF, HGF, and MIP1α, indicating the existence of an intrinsic link among them in MD. Neutrophilic infiltration to the ES or inner ear is necessary to form NETs. It was previously reported that osmotic challenge of the inner ear activated the periaqueductal bone marrow and induced chemotactic attraction of monocytes, neutrophils and eosinophilic leukocytes to the ES38. The detailed mechanism of NET formation remains unclear but it may be caused by chromosomal DNA release following histone depolymerization involving myeloperoxidase, neutrophil elastase, and peptidylarginine deiminase 439. Interestingly, one of the MD patients in the current study carried multiple genetic variants associated with both autoimmune and autoinflammatory reactions and demonstrated vascular congestion over the ES, indicating vasculitis15.
Cytokines potentially engaged in autoimmune reaction of MD
Linear regression demonstrated significant correlations between MIP1α and GCSF, between IL2Rα and GCSF, and between MIP1α and IL8. These results are likely to indicate that MIP1α and IL2Rα might interact with GCSF signaling and that MIP1α might also interact with IL8 signaling in MD. MIP1α and MIP1β are C-C chemokines and exhibit different chemoattractant potentials; human MIP1β tends to attract CD4+ T lymphocytes, while human MIP1α appears to be a more potent chemoattractant with a broader specificity, attracting B cells and cytotoxic T cells as well as CD4+ T cells40. In human monocytes, MIP-1α expression might be induced by costimulation with palmitate and TNFα involving the TLR4-IRF3 pathway and then be amplified by oxidative stress41. The expression of MIP-1α in human ES fibroblasts was upregulated upon polyinosinic-polycytidylic acid stimulation through the TLR3 mechanism42. IL-2 plays a role through binding to IL2R in the maintenance of TReg cells and the differentiation of CD4+ and CD8+ T cells into effector T cells and CD8+ T cells into memory cells. IL-2Rα (also known as CD25) is the third chain of the trimeric IL-2R and it functions to increase the affinity of IL-2R for its ligand43.
Linear regression also demonstrated that there was a marginal linear correlation between IP10 and MIP1α, indicating that IP10 may interact with MIP1α signaling. The concentrations of MIG were age-related in the MD group but not in the control group. Both IP-10 and MIG are ligands of the CXCR3 receptor that are expressed in Th1 cells, B cells, NK cells, dendritic cells, activated T lymphocytes, epithelial cells, and endothelial cells. CXCR3 signaling is involved in the recruitment of activated T cells and the development of autoimmune diseases44,45,46,47,48,49,50.
The concentrations of CTACK were age-related in the MD group but not in the control group, and linear regression showed a significant correlation between SCF and CTACK. CTACK/CCL27 is another C-C chemokine that was originally detected in the mouse epidermis and keratinocyte of human skin and it selectively chemoattracts CLA+ memory T cells51. CTACK plays a critical role in skin allergic processes, including atopic dermatitis and delayed-type hypersensitivity reactions52,53. TNFα and IL1β induce CCL27 production, whereas glucocorticosteroid suppresses it52. CTACK seems to be involved in several disease processes, such as in multiple sclerosis patients (appearing in the sera and cerebral spinal fluids)54,55 and in chronic obstructive pulmonary disease patients (in the sera)56. Higher serum levels of CTACK together with other cytokines in multiple sclerosis patients were associated with more severe disabilities than mild forms57. Human ES luminal fluid contains keratin types I and II and other skin-specific proteins58, which may come from inner ear epithelium facing the endolymph. CTACK may also be produced in the human inner ear in a mechanism similar to that in the skin59. The present study also showed that higher levels of CTACK, IP-10, and MIG were associated to comorbidity of MD and hypertension, and there were positive age-related correlations of CTACK in the MD group but not in the control group. These results are likely to indicate that both C-C and CXCR3 chemokine signaling induced autoimmune reaction may play a role in the more severe disease among aged persons along with the progressing of MD that was found in multiple sclerosis44,45,46,47,48,49,50,57. SCF is the principal growth factor of mast cells and is secreted by fibroblasts, stromal cells, and endothelial cells. Through binding to the c-Kit receptor, SCF-induced signaling mediates inflammatory and allergic diseases with the autoimmune mechanism60,61.
Cytokines potentially engaged in autoinflammation of MD
Kendall’s tau analysis showed that the cytokines IL1α, IL16, bFGF, ILR2α, IL4, LIF, IL1β, and TNFα could form one additional activation branch. Familial Mediterranean fever is an autoinflammatory disease in which large amounts of IL-1β-bearing NETs are released during attacks, and the NETs further amplify IL-1β production by peripheral blood mononuclear cells62. It is well known that both IL1α and IL1β activate the same receptor and induce similar biological effects, but IL1α is present in healthy cells in a wide variety of cells and it is expressed in hematopoietic and nonhematopoietic cells63. TNF receptor activation was also indicated in the development of autoinflammatory disease64,65.
There is an obvious limitation in the study, which is that NET formation in MD was not directly proven, although it was indicated by elevated chemokines. Nine patients with MD had hypertension under treatment. The hypertension could alter the cytokine profile as we observed that these 9 patients differed from other MDs by CTACK, IP10, MIG, IFNγ, and IL4 levels. However, CTACK, IP10, MIG, and were reportedly associated with age instead of hypertension66. In the present study, GCSF, IL8, HGF, MIP1α, TRAIL, and PDGFBB in patients with MD were not influenced by hypertension. Therefore, hypertension does not contribute to the mechanism of potential NET formation in MD. Hypertension seems to influence the vertigo attacks and quality of life67. Thus, hypertension may be regarded mainly as contributory factors affecting the complaint pattern but so far very few epidemiological studies have been carried out in this aspect. As the hypertension is not considered to be etiological factor in MD, we did not remove these patients. But this observation warrants a further study to control hypertension as a possible confounder in cytokine analysis. This study was carried out in the non-ictal phase of the disease. It would be important to know which cytokines are involved in the ictal phase of MD. This would help us to further explore the pathophysiological mechanisms of MD.
The current study demonstrated that G-CSF, IL8, HGF, CTACK, and MIP1α have diagnostic relevance for MD. G-CSF, IL8, and HGF are involved in the development of NETs and influence the functions of macrophages, lymphocytes, and dendritic cells, among others, through various mechanisms involved in MD. Biomarkers identified in the present study may suggest that both autoimmune and autoinflammatory mechanisms are involved in MD. In the future, it will be valuable to develop a cost-effective method to detect G-CSF, IL8, HGF, CTACK, MIP1α, TRAIL, and PDGFBB in the serum of patient that have diagnostic relevance.
All data generated or analyzed during this study are included in this published article.
Area under the curve
Cutaneous T-cell attracting chemokine
Cutaneous lymphocyte-associated antigen
Basic fibroblast growth factor
Granulocyte colony-stimulating factor
Gadolinium-diethylenetriamine pentaacetic acid
Granulocyte-macrophage colony-stimulating factor
Growth related oncogene-α
Hepatocyte growth factor
- IFN-α2, IFN-γ:
- IL-1α, IL-1β, IL-1Rα, IL-2, IL-2Rα, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-12 (p40), IL-12 (p70), IL-13, IL-15, IL-16, IL-17, IL-18:
Interlukin-1α, -1β, -1 receptor-α, -2, -2 receptor-α, -3, -4, -5, -6, -7, -8, -9, -10, -12-β chain, 12 heterodimer of α and β chains, -13, -15, -16, -17, -18
IFN-induced chemokine protein 10
Leukemia inhibitory factor
- MCP-1, MCP-3:
Monocyte chemoattractant protein-1, -3
Macrophage colony-stimulating factor
Macrophage migration inhibitory factor
Monokine induced by IFN-γ
- MIP-1α, MIP-1β:
Macrophage inflammatory protein-1α, -1β
Nerve growth factor-β
Normalized hearing level
Nod-like receptor protein 3
Protein arginine deiminase-4
Platelet-derived growth factor-BB
Regulated on activation, normal T-cell expressed and secreted
Receiver operating characteristic
Stem cell factor
Stem cell growth factor-β
Stromal cell-derived factor-1α
- TNF-α, TNF-β:
Tumor necrosis factor-α, -β
TNF-related apoptosis-inducing ligand
- TReg :
Vascular endothelial growth factor
Basura, G. J. et al. Clinical practice guideline: Meniere’s disease. Otolaryngol. Head Neck Surg. 162(2_suppl), S1–S55 (2020).
Nakashima, T. et al. Meniere’s disease. Nat. Rev. Dis. Primers. 2, 16028 (2016).
Boleas-Aguirre, M. S., Lin, F. R., Della Santina, C. C., Minor, L. B. & Carey, J. P. Longitudinal results with intratympanic dexamethasone in the treatment of Meniere’s disease. Otol. Neurotol. 29(1), 33–38 (2008).
Patel, M. et al. Intratympanic methylprednisolone versus gentamicin in patients with unilateral Meniere’s disease: A randomised, double-blind, comparative effectiveness trial. Lancet 388(10061), 2753–2762 (2016).
Brookes, G. B. Circulating immune complexes in Meniere’s disease. Arch. Otolaryngol. Head Neck Surg. 112(5), 536–540 (1986).
Riente, L. et al. Antibodies to inner ear antigens in Meniere’s disease. Clin. Exp. Immunol. 135(1), 159–163 (2004).
Hietikko, E., Sorri, M., Mannikko, M. & Kotimaki, J. Higher prevalence of autoimmune diseases and longer spells of vertigo in patients affected with familial Meniere’s disease: A clinical comparison of familial and sporadic Meniere’s disease. Am. J. Audiol. 23(2), 232–237 (2014).
Kim, S. Y. et al. Association between Meniere’s disease and thyroid diseases: A nested case–control study. Sci. Rep. 10(1), 18224 (2020).
Fattori, B. et al. Possible association between thyroid autoimmunity and Meniere’s disease. Clin. Exp. Immunol. 152(1), 28–32 (2008).
Frejo, L. et al. Clinical subgroups in bilateral meniere disease. Front. Neurol. 7, 182 (2016).
Frejo, L. et al. Extended phenotype and clinical subgroups in unilateral Meniere disease: A cross-sectional study with cluster analysis. Clin. Otolaryngol. 42(6), 1172–1180 (2017).
Greco, A. et al. Cogan’s syndrome: An autoimmune inner ear disease. Autoimmun. Rev. 12(3), 396–400 (2013).
Frejo, L. et al. Proinflammatory cytokines and response to molds in mononuclear cells of patients with Meniere disease. Sci. Rep. 8(1), 5974 (2018).
Zou, J. Autoinflammatory characteristics and short-term effects of delivering high-dose steroids to the surface of the intact endolymphatic sac and incus in refractory Meniere’s disease. J. Otol. 14(2), 40–50 (2019).
Zou, J., Zhao, Z., Zhang, G., Zhang, Q. & Pyykko, I. MEFV, IRF8, ADA, PEPD, and NBAS gene variants and elevated serum cytokines in a patient with unilateral sporadic Meniere’s disease and vascular congestion over the endolymphatic sac. J. Otol. 17(3), 175–181 (2022).
Moller, M. N., Kirkeby, S., Vikesa, J., Nielsen, F. C. & Caye-Thomasen, P. Gene expression demonstrates an immunological capacity of the human endolymphatic sac. Laryngoscope 125(8), E269–E275 (2015).
Kim, S. H. et al. Autoimmunity as a candidate for the etiopathogenesis of Meniere’s disease: Detection of autoimmune reactions and diagnostic biomarker candidate. PLoS ONE 9(10), e111039 (2014).
Oh, E. H. et al. Rare variants of putative candidate genes associated with sporadic meniere’s disease in East Asian population. Front. Neurol. 10, 1424 (2019).
Szekanecz, Z. et al. Autoinflammation and autoimmunity across rheumatic and musculoskeletal diseases. Nat. Rev. Rheumatol. 17(10), 585–595 (2021).
Hussain, M. T., Iqbal, A. J. & Norling, L. V. The role and impact of extracellular vesicles in the modulation and delivery of cytokines during autoimmunity. Int. J. Mol. Sci. 21(19), 7096 (2020).
Meier-Schiesser, B. & French, L. E. Autoinflammatory syndromes. J. Dtsch. Dermatol. Ges. 19(3), 400–426 (2021).
Ou-Yang, L. J. & Tang, K. T. A case of adult onset Still’s disease with mutations of the MEFV gene who is partially responsive to colchicine. Medicine (Baltimore) 97(15), e0333 (2018).
McGonagle, D. & McDermott, M. F. A proposed classification of the immunological diseases. PLoS Med. 3(8), e297 (2006).
WMA Declaration of Helsinki—Ethical Principles for Medical Research Involving Human Subjects: World Medical Association [Internet]. 2014. http://www.wma.net/en/30publications/10policies/b3/.
Lopez-Escamez, J. A. et al. Diagnostic criteria for Meniere’s disease. J Vestib Res. 25(1), 1–7 (2015).
Mandrekar, J. N. Receiver operating characteristic curve in diagnostic test assessment. J. Thorac. Oncol. 5(9), 1315–1316 (2010).
Teijeira, A. et al. CXCR1 and CXCR2 chemokine receptor agonists produced by tumors induce neutrophil extracellular traps that interfere with immune cytotoxicity. Immunity 52(5), 856-871e8 (2020).
Rollins, B. J. Chemokines. Blood 90(3), 909–928 (1997).
Demers, M. et al. Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis. Proc Natl Acad Sci USA 109(32), 13076–13081 (2012).
Giaglis, S. et al. Multimodal regulation of NET formation in pregnancy: Progesterone antagonizes the pro-NETotic effect of estrogen and G-CSF. Front Immunol. 7, 565 (2016).
Brinkmann, V. et al. Neutrophil extracellular traps kill bacteria. Science 303(5663), 1532–1535 (2004).
Klopf, J., Brostjan, C., Eilenberg, W. & Neumayer, C. Neutrophil extracellular traps and their implications in cardiovascular and inflammatory disease. Int. J. Mol. Sci. 22(2), 559 (2021).
Jorch, S. K. & Kubes, P. An emerging role for neutrophil extracellular traps in noninfectious disease. Nat. Med. 23(3), 279–287 (2017).
Sag, D., Ayyildiz, Z. O., Gunalp, S. & Wingender, G. The role of TRAIL/DRs in the modulation of immune cells and responses. Cancers (Basel). 11(10), 1469 (2019).
Chen, L. et al. Inhibition of PDGF-BB reduces alkali-induced corneal neovascularization in mice. Mol. Med. Rep. 23(4), 1–1 (2021).
Urdang, Z. D., Bills, J. L., Cahana, D. Y., Muldoon, L. L. & Neuwelt, E. A. Toll-like receptor 4 signaling and downstream neutrophilic inflammation mediate endotoxemia-enhanced blood-labyrinth barrier trafficking. Otol. Neurotol. 41(1), 123–132 (2020).
Schultz, J. M. et al. Noncoding mutations of HGF are associated with nonsyndromic hearing loss, DFNB39. Am. J. Hum. Genet. 85(1), 25–39 (2009).
Jansson, B. & Rask-Andersen, H. Osmotically induced macrophage activity in the endolymphatic sac. On the possible interaction between periaqueductal bone marrow cells and the endolymphatic sac. ORL J. Otorhinolaryngol. Relat. Spec. 54(4), 191–197 (1992).
Castillo, F. et al. Levels of low-molecular-weight hyaluronan in periodontitis-treated patients and its immunostimulatory effects on CD4(+) T lymphocytes. Clin. Oral Investig. 25(8), 4987–5000 (2021).
Schall, T. J., Bacon, K., Camp, R. D., Kaspari, J. W. & Goeddel, D. V. Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes. J. Exp. Med. 177(6), 1821–1826 (1993).
Sindhu, S. et al. MIP-1alpha expression induced by co-stimulation of human monocytic cells with palmitate and TNF-alpha Involves the TLR4-IRF3 pathway and is amplified by oxidative stress. Cells 9(8), 1799 (2020).
Yamada, T. et al. Toll-like receptor ligands induce cytokine and chemokine production in human inner ear endolymphatic sac fibroblasts. Auris Nasus Larynx 44(4), 398–403 (2017).
Boyman, O. & Sprent, J. The role of interleukin-2 during homeostasis and activation of the immune system. Nat. Rev. Immunol. 12(3), 180–190 (2012).
Torres-Vazquez, J. et al. Relationship of IP-10 gene expression to systemic lupus erythematosus activity. Reumatol. Clin. (Engl. Ed.). 18(2), 91–93 (2022).
El-Domyati, M. et al. Systemic CXCL10 is a predictive biomarker of vitiligo lesional skin infiltration, PUVA, NB-UVB and corticosteroid treatment response and outcome. Arch. Dermatol. Res. 314(3), 275–284 (2022).
De Paepe, B., Bracke, K. R. & De Bleecker, J. L. An exploratory study of circulating cytokines and chemokines in patients with muscle disorders proposes CD40L and CCL5 represent general disease markers while CXCL10 differentiates between patients with an autoimmune myositis. Cytokine X 4(1), 100063 (2022).
Pezzano, M. MIG in autoimmune thyroiditis: review of the literature. Clin Ter. 170(4), e295–e300 (2019).
Ruffilli, I. MIG in cutaneous systemic lupus erythematosus. Clin Ter. 170(1), e71–e76 (2019).
Ruffilli, I. Sjogren syndrome and MIG. Clin. Ter. 170(6), e478–e482 (2019).
Smit, M. J. et al. CXCR3-mediated chemotaxis of human T cells is regulated by a Gi- and phospholipase C-dependent pathway and not via activation of MEK/p44/p42 MAPK nor Akt/PI-3 kinase. Blood 102(6), 1959–1965 (2003).
Morales, J. et al. CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells. Proc. Natl. Acad. Sci. USA 96(25), 14470–14475 (1999).
Homey, B. et al. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat. Med. 8(2), 157–165 (2002).
Huang, V. et al. Cutting edge: Rapid accumulation of epidermal CCL27 in skin-draining lymph nodes following topical application of a contact sensitizer recruits CCR10-expressing T cells. J. Immunol. 180(10), 6462–6466 (2008).
Khaiboullina, S. F. et al. CCL27: Novel cytokine with potential role in pathogenesis of multiple sclerosis. Biomed. Res. Int. 2015, 189638 (2015).
Khaibullin, T. et al. Elevated levels of proinflammatory cytokines in cerebrospinal fluid of multiple sclerosis patients. Front. Immunol. 8, 531 (2017).
Bade, G. et al. Serum cytokine profiling and enrichment analysis reveal the involvement of immunological and inflammatory pathways in stable patients with chronic obstructive pulmonary disease. Int. J. Chron. Obstruct. Pulmon. Dis. 9, 759–773 (2014).
Kouchaki, E. et al. Correlation of serum levels of interleukine-16, CCL27, tumor necrosis factor-related apoptosis-inducing ligand, and B-cell activating factor with multiple sclerosis severity. Iran. J. Allergy Asthma Immunol. 21(1), 27–34 (2022).
Olander, C. et al. The proteome of the human endolymphatic sac endolymph. Sci. Rep. 11(1), 11850 (2021).
Bragulla, H. H. & Homberger, D. G. Structure and functions of keratin proteins in simple, stratified, keratinized and cornified epithelia. J. Anat. 214(4), 516–559 (2009).
Teegala, L. R. et al. Protein Kinase C alpha and beta compensate for each other to promote stem cell factor-mediated KIT phosphorylation, mast cell viability and proliferation. FASEB J. 36(5), e22273 (2022).
Lei, Z. et al. SCF and IL-31 rather than IL-17 and BAFF are potential indicators in patients with allergic asthma. Allergy 63(3), 327–332 (2008).
Skendros, P., Papagoras, C., Mitroulis, I. & Ritis, K. Autoinflammation: Lessons from the study of familial Mediterranean fever. J. Autoimmun. 104, 102305 (2019).
Di Paolo, N. C. & Shayakhmetov, D. M. Interleukin 1alpha and the inflammatory process. Nat. Immunol. 17(8), 906–913 (2016).
Kitagawa, Y. et al. Anti-TNF treatment corrects IFN-gamma-dependent proinflammatory signatures in Blau syndrome patient-derived macrophages. J. Allergy Clin. Immunol. 149(1), 176-188 e7 (2022).
Matsuda, T. et al. Potential benefits of TNF targeting therapy in Blau syndrome, a NOD2-associated systemic autoinflammatory granulomatosis. Front. Immunol. 13, 895765 (2022).
Jalkanen, J., Hollmen, M., Maksimow, M., Jalkanen, S. & Hakovirta, H. Serum cytokine levels differ according to major cardiovascular risk factors in patients with lower limb atherosclerosis. Cytokine 114, 74–80 (2019).
Molnar, A., Stefani, M., Tamas, L. & Szirmai, A. Possible effect of diabetes and hypertension on the quality of life of patients suffering from Meniere’s disease. Orv. Hetil. 160(4), 144–150 (2019).
We thank all the patients and healthy volunteers for their generous donations of blood samples. We thank the nurses of the department for collecting blood samples.
This study was supported by a grant from The National Natural Science Foundation of China (No. 81771006).
The authors declare no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Zou, J., Zhao, Z., Song, X. et al. Elevated G-CSF, IL8, and HGF in patients with definite Meniere’s disease may indicate the role of NET formation in triggering autoimmunity and autoinflammation. Sci Rep 12, 16309 (2022). https://doi.org/10.1038/s41598-022-20774-8